Tenzer Stefan, Crawford Hayley, Pymm Phillip, Gifford Robert, Sreenu Vattipally B, Weimershaus Mirjana, de Oliveira Tulio, Burgevin Anne, Gerstoft Jan, Akkad Nadja, Lunn Daniel, Fugger Lars, Bell John, Schild Hansjörg, van Endert Peter, Iversen Astrid K N
Institute of Immunology, University Medical Center of the Johannes-Gutenberg University of Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany.
Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UK; Division of Clinical Neurology, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UK.
Cell Rep. 2014 Apr 24;7(2):448-463. doi: 10.1016/j.celrep.2014.03.031. Epub 2014 Apr 13.
The recent HIV-1 vaccine failures highlight the need to better understand virus-host interactions. One key question is why CD8(+) T cell responses to two HIV-Gag regions are uniquely associated with delayed disease progression only in patients expressing a few rare HLA class I variants when these regions encode epitopes presented by ~30 more common HLA variants. By combining epitope processing and computational analyses of the two HIV subtypes responsible for ~60% of worldwide infections, we identified a hitherto unrecognized adaptation to the antigen-processing machinery through substitutions at subtype-specific motifs. Multiple HLA variants presenting epitopes situated next to a given subtype-specific motif drive selection at this subtype-specific position, and epitope abundances correlate inversely with the HLA frequency distribution in affected populations. This adaptation reflects the sum of intrapatient adaptations, is predictable, facilitates viral subtype diversification, and increases global HIV diversity. Because low epitope abundance is associated with infrequent and weak T cell responses, this most likely results in both population-level immune evasion and inadequate responses in most people vaccinated with natural HIV-1 sequence constructs. Our results suggest that artificial sequence modifications at subtype-specific positions in vitro could refocus and reverse the poor immunogenicity of HIV proteins.
近期HIV-1疫苗研发的失败凸显了深入了解病毒与宿主相互作用的必要性。一个关键问题是,在两个HIV-Gag区域编码的表位可由约30种更常见的HLA I类变体呈递,然而为何针对这两个区域的CD8(+) T细胞反应仅在表达少数罕见HLA I类变体的患者中与疾病进展延迟存在独特关联。通过结合对导致全球约60%感染的两种HIV亚型的表位加工和计算分析,我们发现了一种此前未被认识到的通过亚型特异性基序处的替换来适应抗原加工机制的现象。多个呈递位于给定亚型特异性基序旁表位的HLA变体在该亚型特异性位置驱动选择,且表位丰度与受影响人群中的HLA频率分布呈负相关。这种适应反映了患者体内适应的总和,具有可预测性,促进了病毒亚型多样化,并增加了全球HIV的多样性。由于低表位丰度与罕见且微弱的T细胞反应相关,这很可能导致群体层面的免疫逃逸以及大多数接种天然HIV-1序列构建体疫苗的人产生不充分的反应。我们的结果表明,体外对亚型特异性位置进行人工序列修饰可能会重新聚焦并扭转HIV蛋白免疫原性差的问题。